Effects of Mechanical Ventilation Guided by Transpulmonary Pressure on Gas Exchange During Robotic Surgery: a Pilot Study (Vetrapo)

July 1, 2019 updated by: Gianmaria Cammarota, Azienda Ospedaliero Universitaria Maggiore della Carita

Effects of Mechanical Ventilation Guided by Transpulmonary Pressure on Gas Exchange During Robotic Surgery

Laparoscopy and robotic techniques are widespread procedures for pelvic gynecologic, urologic and abdominal surgery often performed in Trendelenburg position, with the application of pneumoperitoneum by inflating carbon dioxide. The rise in abdominal pressure following pneumoperitoneum and the head down body position have been shown to impair the respiratory function during the procedure, mainly inducing atelectasis formation in the dependent lung regions, worsening stress and strain of the alveolar structure.

The application of a ventilator strategy providing positive end-expiratory pressure (PEEP) has been shown to reduce the diaphragm cranial shift, increasing functional residual capacity and decreasing respiratory system elastance. Furthermore, the application of recruiting maneuver followed by the subsequent application of PEEP improved oxygenation. These results are in accordance with finding by Talmor et al, evaluating the effect of a mechanical ventilation guided by esophageal pressure in acute lung injury patients.

However a comparison between an esophageal pressure piloted mechanical ventilation and a conventional low tidal ventilator strategy with adjunct of PEEP and recruitment maneuvers according to clinical judgment has never been investigated in patients undergoing robotic gynecologic, abdominal or urologic surgery. The investigators aim to compare the conventional ventilation strategy (i.e. with application of PEEP and recruitment manoeuvre) with a ventilation driven by transpulmonary pressure assessed through an esophageal catheter, in patients undergoing to robotic surgery, with respect to oxygenation, expressed in terms of arterial oxygen tension - inspired oxygen fraction ratio (PaO2/FiO2) (primary endpoint), intraoperative respiratory mechanics indexes, number of lung recruitment maneuvers, rate and type of perioperative complications until hospital discharge (additional endpoint).

Study Overview

Detailed Description

INTRODUCTION Laparoscopy and robotic techniques are widespread procedures for pelvic gynecologic, urologic and abdominal surgery often performed in Trendelenburg position. Furthermore, in order to ameliorate surgical procedures, pneumoperitoneum is applied by inflating carbon dioxide. However, the rise in abdominal pressure following pneumoperitoneum and the head down body position have been shown to impair the respiratory function during the procedure, mainly inducing atelectasis formation in the declive lung regions. Consequently, functional residual capacity decreases and the risk of perioperative complications, such as hypoxaemia, rises up, particularly if patients are obese. Formation of atelectasis may worsen stress and strain of the alveolar structure. Stress, strain and atelectrauma give rise to ventilator-induced lung injury.

Although the role of ventilator-induced lung injury during general anesthesia is unclear, several investigations have been conducted with the purpose of improving arterial oxygenation and respiratory mechanics during laparoscopy. A ventilator strategy providing positive end-expiratory pressure (PEEP) has been shown to reduce the diaphragm cranial shift, increasing functional residual capacity and decreasing respiratory system elastance, principally in the obese subjects. Furthermore, the application of recruiting maneuver followed by the subsequent application of PEEP improved oxygenation during laparoscopy. Cinnella et al. demonstrated that an open lung strategy, i.e. a ventilation supported by recruiting maneuvers followed by the subsequent application of PEEP applied after pneumoperitoneum induction, increased transpulmonary pressure and led to alveolar recruitment and improvement of elastance of chest wall and gas exchange. These results are in accordance with finding by Talmor et al, evaluating the effect of a mechanical ventilation guided by esophageal pressure in acute lung injury patients.

However a comparison between an esophageal pressure piloted mechanical ventilation and a conventional low tidal ventilator strategy with adjunct of PEEP and recruitment maneuvers according to clinical judgment has never been investigated in patients undergoing robotic gynecologic, abdominal or urologic surgery.

Aim The investigators aim to compare the conventional ventilation strategy (i.e., with application of PEEP and recruitment manoeuvre) with a ventilation driven by transpulmonary pressure assessed through an esophageal catheter, in patients undergoing to robotic surgery, with respect to oxygenation, expressed in terms of arterial oxygen tension - inspired oxygen fraction ratio (PaO2/FiO2) (primary endpoint), intraoperative respiratory mechanics indexes, number of lung recruitment maneuvers, rate and type of perioperative complications until hospital discharge (additional endpoint).

METHODS Patients For this protocol, after informed consent has been obtained, 26 patients will be enrolled in the pilot randomized interventional study, eligible for robotic gynecological, urological and abdominal surgery at Maggiore Hospital Novara Italy.

  1. The inclusion criteria will be: minimum age 18 years old, ASA I-II.
  2. The exclusion criteria are: pre-existing lung and cardiac conditions that may lead to asa> II, contraindications to the positioning of a naso-gastric tube.

Intervention After the induction of general anesthesia, a naso-gastric tube equipped with gastric and esophageal balloon will be inserted (Nutrivent® - Seda). The nasogastric tube will be positioned and the esophageal balloon will be calibrated according to the findings by Mojoli et al.

In this phase, all patients will be ventilated a tidal volume (VT) of 6-8 ml / kg, in a volume controlled mode; PEEP (positive end-expiratory pressure) equal to zero and FiO2 set to obtain peripheral oxygen saturation (SpO2) > or = to 94% . The respiratory rate will be set to obtain arterial carbon dioxide tension (PaCO2) values between 35 and 45 mmHg and to ensure a physiological pH. At most, both a mild hypercapnia and a mild acidosis will be allowed.

In all the patients radial artery will be cannulated to monitor continuous intra-arterial blood pressure as usual practice, after Allen test results positive. The invasive hemodynamic monitoring will be performed through MOSTCARETM technology.

Subsequently, pneumoperitoneum will be applied to the patients, and the final position on the surgical table will be guaranteed. At this point, a recruitment maneuver will be applied, i.e., the ventilator is switched to pressure control ventilation, inspiratory time is increased to 50%, the peak inspiratory pressure gradient (above PEEP) is set at 20 cm H2O, and PEEP is progressively increased to obtain a stepwise increase of peak inspiratory to 30, 35, and 40 cm H2O every three breaths. The final recruiting pressure of 40 cm H2O is applied for six breaths. after recruiting maneuver ventilator is switched to previous ventilation mode. This maneuver is normally used to distend the lungs and prevent atelectasis .

Then, patients will be randomized into two groups according to a randomization list generated by a dedicated software. Clinician, at the surgical table, will open a sequentially numbered, opaque, sealed envelope to allocate the patient according to the randomization group. A researcher, not involved in the clinical care of the patient, will keep the randomization list. Patients will be randomized into:

  1. Control group: 13 ventilated patients in Volume controlled VT 6-8 ml / kg; PEEP, and Fio2 (fraction of inspired oxygen) set for SpO2> or = to 94%, Plateau pressure <28 cm H2O.
  2. Case group: 13 ventilated patients with current volume VT 6-8 ml / kg and in any case with a transpulmonary inspiratory pressure (PLinsp) of less than 20 cmH2O and transpulmonary expiratory pressure (PLexp) - FiO2, according to predefined criteria.

In both groups the respiratory rate will be set to obtain PaCO2 values between 35 and 45 mmHg and in any case to ensure a physiological pH. In addition, whenever the clinician will deem it appropriate, an alveolar recruitment maneuver will be applied, as previously described, in order to improve the PaO2 / FiO2 relationship.

Safety criteria In the intervention group in case of SpO2< to 94%, alveolar recruitment maneuvers will be applied.

Measurements During the study the following parameters will be recorded: arterial blood gas, respiratory mechanics parameters (airway pressure, tidal volume, transpulmonary pressure, flow, esophageal pressure),peritoneal insufflation pressure.

These measurement will be will be performed at:

1) 15 min after induction of anesthesia (STEP 1) 2) immediately after the positioning of the patient and / or the pneumoperitoneum induction (STEP 2) 3) immediately after the recruitment maneuver (STEP 3) 4) 20 minutes after the application of the ventilatory strategy select with the randomization (STEP 4) 5) after 60 minutes from the application of the ventilatory strategy select with the randomization (STEP 5) 7) every 60 minutes from the last step (STEP 6) 8) at the end of surgery after the elimination of the pneumo-peritoneum and / or in the supine position (STEP 7).

9) 1h after recovery from anesthesia (STEP 8). With the patient awake (i.e.before and after surgery), a lung ultrasound will be carried out to evaluate the degree of ventilation / atelectasis .

Statistical analysis For this pilot randomized study, was calculated a sample size of 26 patients in total i.e., 13 patients per arm . To determine sample size, the investigators expected a difference of 80 mmHg between the mean value of PaO2/FiO2 of the two groups and a standard deviation of 60 mmHg, with a power of 80% and an alpha of 0.05.

The continuous variables will be presented as the median and interquartile and will be compared using the Mann Whitney test. Categorical variables, whether dichotomous or nominal, will be evaluated with a Fisher test. A trend analysis will be carried out within each group over the course of each step.

Study Type

Interventional

Enrollment (Actual)

28

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Novara, Italy, 28100
        • AOU Maggiore della Carità

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • American Society of Anesthesiologists (ASA) score I - II
  • Patients requiring elective robotic gynecological-abdominal surgery

Exclusion Criteria:

- Contraindications to the positioning of a naso-gastric tube

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: SUPPORTIVE_CARE
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: conventional ventilation strategy
13 patients will undergo volume controlled ventilation set with a tidal volume between 6-8 ml/kg of ideal body weight, positive end-expiratory pressure and fraction of inspired oxygen set to obtain a peripheral saturation in oxygen equal or greater than 94% and a plateau pressure <28 cmH2O.
13 patients will undergo volume controlled ventilation set with a tidal volume between 6-8 ml/kg of ideal body weight, positive end-expiratory pressure and fraction of inspired oxygen set to obtain a peripheral saturation in oxygen equal or greater than 94% and a plateau pressure <28 cmH2O Respiratory rate will be set to obtain an arterial partial pressure of carbon dioxide between 35 and 45 mmHg and in any case to ensure a physiological pH. In addition, whenever the clinician will deem it appropriate, an alveolar recruitment maneuver will be performed as previously described
EXPERIMENTAL: transpulmonary pressure strategy
13 patients will undergo volume controlled ventilation set with a tidal volume at 6-8 ml/kg of ideal body weight, and with a inspiratory transpulmonary pressure less than 20 cmH2O and an expiratory transpulmonary pressure and inspired oxygen set accordingly to predefined criteria.
Patients will receive volume controlled ventilation set with a tidal volume at 6-8 ml/kg of ideal body weight, an inspiratory transpulmonary pressure less than 20 cmH2O, and an expiratory transpulmonary pressure (PLexp) equal or greater than 0. At PLexp increasing from 0 up to 10 cmH2O, inspired fraction of oxygen would also be increased from 40% to 100%. Respiratory rate will be set to obtain an arterial partial pressure of carbon dioxide between 35 and 45 mmHg and to ensure a physiological pH. Whenever the clinician will deem it appropriate, an alveolar recruitment maneuver as previously described

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oxygenation Changes
Time Frame: Soon after anesthesia induction (step 1), after 45 min from step 1 (pneumoperitoneum, trendelemburg, recruitment maneuver application-step 2),after 20min from randomization (step 3), every 60 min during surgery and at its end, after 1 hour from recovery.
Ratio between the arterial partial pressure (PaO2) and inspired fraction (FiO2) of oxygen (PaO2/FiO2)
Soon after anesthesia induction (step 1), after 45 min from step 1 (pneumoperitoneum, trendelemburg, recruitment maneuver application-step 2),after 20min from randomization (step 3), every 60 min during surgery and at its end, after 1 hour from recovery.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intraoperative respiratory mechanics indexes changes
Time Frame: Soon after anesthesia induction (step 1), after 45 min from step 1 (pneumoperitoneum, trendelemburg, recruitment maneuver application-step 2),after 20min from randomization (step 3), every 60 min during surgery and at its end, after 1 hour from recovery.
Airway pressure, flow, esophageal and transpulmonary pressures
Soon after anesthesia induction (step 1), after 45 min from step 1 (pneumoperitoneum, trendelemburg, recruitment maneuver application-step 2),after 20min from randomization (step 3), every 60 min during surgery and at its end, after 1 hour from recovery.
Number of lung recruitment maneuvers
Time Frame: During the whole surgical procedure
The number of recruitment maneuvers required during the surgery will be recorded
During the whole surgical procedure
Type of perioperative complications
Time Frame: within the following 30 days after surgery
postoperative hypoxemia, presence of lung atelectasis, occurrence of pneumonia, sepsis, severe sepsis or septic shock
within the following 30 days after surgery
Rate of perioperative complications
Time Frame: within the following 30 days after surgery
Number of perioperative complication occurred during the hospital length of stay
within the following 30 days after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

September 14, 2017

Primary Completion (ACTUAL)

May 30, 2019

Study Completion (ACTUAL)

May 30, 2019

Study Registration Dates

First Submitted

May 12, 2017

First Submitted That Met QC Criteria

May 12, 2017

First Posted (ACTUAL)

May 15, 2017

Study Record Updates

Last Update Posted (ACTUAL)

July 2, 2019

Last Update Submitted That Met QC Criteria

July 1, 2019

Last Verified

July 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • CE 62/17

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Surgery

Clinical Trials on Conventional ventilation strategy

3
Subscribe